Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 228 of the 230 references it cites were found in a registry or an index.

Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes

Open access
Shivaswamy, Vijay, Boerner, Brian, Larsen, Jennifer · 2016 · Endocrine Reviews

Abstract

Post-transplant diabetes mellitus (PTDM) is a frequent consequence of solid organ transplantation. PTDM has been associated with greater mortality and increased infections in different transplant groups using different diagnostic criteria. An international consensus panel recommended a consistent set of guidelines in 2003 based on American Diabetes Association glucose criteria but did not exclude the immediate post-transplant hospitalization when many patients receive large doses of corticosteroids. Greater glucose monitoring during all hospitalizations has revealed significant glucose intolerance in the majority of recipients immediately after transplant. As a result, the international consensus panel reviewed its earlier guidelines and recommended delaying screening and diagnosis of PTDM until the recipient is on stable doses of immunosuppression after discharge from initial transplant hospitalization. The group cautioned that whereas hemoglobin A1C has been adopted as a diagnostic criterion by many, it is not reliable as the sole diabetes screening method during the first year after transplant. Risk factors for PTDM include many of the immunosuppressant medications themselves as well as those for type 2 diabetes. The provider managing diabetes and associated dyslipidemia and hypertension after transplant must be careful of the greater risk for drug-drug interactions and infections with immunosuppressant medications. Treatment goals and therapies must consider the greater risk for fluctuating and reduced kidney function, which can cause hypoglycemia. Research is actively focused on strategies to prevent PTDM, but until strategies are found, it is imperative that immunosuppression regimens are chosen based on their evidence to prolong graft survival, not to avoid PTDM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/er.2015-1084

Cites

228 of 228 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 230 references

Cited by

Items 101–200 of 328

Metadata

Authors
Shivaswamy, V., Boerner, B., & Larsen, J.
Affiliations
  • VA Nebraska Western Iowa Health Care System (US)
  • University of Nebraska Medical Center (US)
Corresponding author
Larsen, Jennifer
Venue
Endocrine Reviews
Published
2015-12-09
Volume
37
Issue
1
Pages
37-61
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
OpenAlex
W2190934800
Cited by
328
References
230
Citations by year
2026: 30 · 2025: 36 · 2024: 35 · 2023: 31 · 2022: 32 · 2021: 44 · 2020: 51 · 2019: 29 · 2018: 30 · 2017: 5 · 2016: 4
FWCI
2.81
Type
journal article
Language
en
Open access
Locations
  • Endocrine Reviews (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Veterans Affairs
  • Office of Research and Development
Topics
  • Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
post-transplant diabetes mellitus, solid organ transplantation, immunosuppression, corticosteroids, impaired glucose tolerance, diabetes screening, HbA1c, type 2 diabetes risk factors, drug-drug interactions, hypoglycemia, graft survival, mortality, infection risk, diabetes treatment
MeSH terms
Adrenal Cortex Hormones, Animals, Combined Modality Therapy, Diabetes Mellitus, Graft Rejection, Graft Survival, Humans, Immunosuppressive Agents, Postoperative Complications, Risk Factors, Stress, Physiological, Organ Transplantation, Cost of Illness, Practice Guidelines as Topic, Evidence-Based Medicine, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.